Clinical Trials Logo

Facial Rhytides clinical trials

View clinical trials related to Facial Rhytides.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04609020 Completed - Facial Rhytides Clinical Trials

Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment

Start date: February 15, 2023
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to quantify the psychological, social, and emotional impact of comprehensive aesthetic treatment with a portfolio of the Sponsor's products by measuring the change in subject's satisfaction with facial appearance from baseline (before any treatment) to the final study visit

NCT ID: NCT02261493 Completed - Facial Rhytides Clinical Trials

A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

Start date: October 2014
Phase: Phase 3
Study type: Interventional

This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines [crow's feet lines]).

NCT ID: NCT02176356 Completed - Glabellar Lines Clinical Trials

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Start date: June 30, 2014
Phase: Phase 4
Study type: Interventional

A study to evaluate patient satisfaction, aesthetic and psychological impact of combined treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).

NCT ID: NCT01777620 Completed - Facial Rhytides Clinical Trials

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

Start date: January 31, 2013
Phase: Phase 4
Study type: Interventional

This is a safety and efficacy study of BOTOX® in subjects with facial rhytides (glabellar lines and crow's feet lines).

NCT ID: NCT01608659 Completed - Facial Rhytides Clinical Trials

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Start date: April 1, 2011
Phase:
Study type: Observational

This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.

NCT ID: NCT01600729 Completed - Facial Rhytides Clinical Trials

Reliability of the Facial Wrinkle Scale in Japanese Subjects

Start date: June 2012
Phase: N/A
Study type: Observational

This study will evaluate the inter-rater and intra-rater reliability of the Facial Wrinkle Scale with Asian Photonumeric Guide (FWS-A) in Japanese subjects.

NCT ID: NCT01391299 Completed - Clinical trials for Glabellar Frown Lines

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines

Start date: June 1, 2011
Phase: N/A
Study type: Interventional

This study evaluated the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of forehead lines (facial rhytides) when also administered to frown lines (glabellar rhytides).

NCT ID: NCT01299103 Completed - Facial Rhytides Clinical Trials

Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles

Start date: April 2010
Phase: N/A
Study type: Interventional

This study compares the safety and efficacy of single therapy versus double therapy using the Pellevé™ Wrinkle Treatment System for the treatment of mild to moderate facial wrinkles in Fitzpatrick Skin Types I - IV. Safety is assessed by analysis of adverse events. Efficacy is assessed by change in Fitzpatrick score for facial wrinkles.

NCT ID: NCT01224015 Completed - Glabellar Lines Clinical Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Start date: May 2011
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of botulinum toxin type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides) for patients who successfully completed Study 191622-099.

NCT ID: NCT01189760 Completed - Glabellar Lines Clinical Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Start date: September 1, 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides)